Provenance Wealth Advisors »

TherapeuticsMD shares owned by Provenance Wealth Advisors

Quarter-by-quarter ownership of TherapeuticsMD (TXMD) shares owned by Provenance Wealth Advisors from 13F filings

Historical chart of Provenance Wealth Advisors investment in TherapeuticsMD

Tip: Access up to 7 years of quarterly data

All positions including TherapeuticsMD held by Provenance Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in TherapeuticsMD by Provenance Wealth Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $22 20 1.10
2025-06-30 $23 20 1.15
2025-03-31 $19 20 0.95
2024-12-31 $17 20 0.85
2024-09-30 $33 20 1.65
2024-06-30 $32 20 1.60
2024-03-31 $46 20 2.30
2023-12-31 $45 20 2.25
2023-09-30 $60 20 3.00

More positions owned by Provenance Wealth Advisors

Ishares Tr Core S&p Ttl Stk Core S&p Ttl Stk (ITOT)
Vaneck Morningstar Wide Moat Etf Mrngstr Wde Moat (MOAT)
Vanguard Dividend Appreciation Etf Div App Etf (VIG)
Vanguard Total International Stock Etf Vg Tl Intl Stk F (VXUS)
Jp Morgan Etf Active Growth Etf Active Growth (JGRO)
Ishares Tr Core Us Aggbd Et Core Us Aggbd Et (AGG)
Ishares Tr Msci Emg Mkt Etf Msci Emg Mkt Etf (EEM)
Ishares Tr Russell 3000 Etf Russell 3000 Etf (IWV)
Spdr S&p 500 Etf Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Msci Eafe Etf Msci Eafe Etf (EFA)
Ishares Tr Rus 1000 Grw Etf Rus 1000 Grw Etf (IWF)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)

View all positions for Provenance Wealth Advisors

Top funds holding TherapeuticsMD

Rubric Capital Management
Clearline Capital
Vanguard Group
Tejara Capital
ADAR1 Capital Management
Morgan Stanley
BlackRock
Geode Capital Management
Renaissance Technologies
Citadel Advisors
Bridgeway Capital Management
State Street Corporation
Northern Trust
J. Goldman & Co
Two Sigma Securities

View all funds holding TherapeuticsMD